The use of cardiac resynchronization therapy (CRT) for heart failure
NHS Quality Improvement Scotland
Record ID 32005001414
English
Authors' recommendations:
There is evidence from randomised controlled trials that cardiac resynchronisation therapy (CRT or biventricular pacing) with or without a combined implantable cardioverter defibrillator (CRT/D) improves exercise tolerance, symptoms and quality of life and reduces the number of hospitalisations for heart failure in appropriately selected patients.Randomised controlled trials of CRT or CRT/D have demonstrated a reduction in all cause mortality compared to optimal medical therapy (OMT).The procedure is technically challenging with left ventricular lead implantation problems reported in 10% of patients. Serious complications occur rarely.An economic model suggests that the substantial costs of implantation and follow up can be recouped as a result of cost savings from averted heart failure related hospital admissions. Costeffectiveness analysis has indicated uncertainty in the incremental cost per QALY.
Details
Project Status:
Completed
URL for project:
http://www.nhshealthquality.org/nhsqis/files/EN10%20final.pdf
Year Published:
2005
URL for published report:
http://www.nhshealthquality.org/nhsqis/2771.html
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland
MeSH Terms
- Cardiac Pacing, Artificial
- Heart Failure
Contact
Organisation Name:
Quality Improvement Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
NHS Quality Improvement Scotland (NHS QIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.